Insider Buying: Ondine Biomedical Inc. (LON:OBI) Insider Purchases 25,000 Shares of Stock

Ondine Biomedical Inc. (LON:OBI) insider Nicolas Loebel purchased 25,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 5th. The stock was acquired at an average price of C$13.00 per share, for a total transaction of C$325,000.00.

Ondine Biomedical Stock Performance

Shares of OBI opened at C$12.25 on Thursday. Ondine Biomedical Inc. has a 52-week low of C$4.50 and a 52-week high of C$13.30. The company has a quick ratio of 8.26, a current ratio of 0.80 and a debt-to-equity ratio of 1,847.37. The company has a market capitalization of C$3.40 billion, a PE ratio of -408.33 and a beta of 0.10. The company has a 50-day simple moving average of C$9.43 and a 200-day simple moving average of C$8.07.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.